WO2025209520 - COMPOUND, PHARMACEUTICAL COMPOSITION COMPRISING SAME, AND USE THEREOF
National phase entry is expected:
Publication Number
WO/2025/209520
Publication Date
09.10.2025
International Application No.
PCT/CN2025/086833
International Filing Date
02.04.2025
Title **
[English]
COMPOUND, PHARMACEUTICAL COMPOSITION COMPRISING SAME, AND USE THEREOF
[French]
COMPOSÉ, COMPOSITION PHARMACEUTIQUE LE CONTENANT ET SON UTILISATION
[Chinese]
一种化合物、包含其的药物组合物及其用途
Applicants **
DOVETREE MEDICINES UNUS, INC.
Inventors
DENG, Xinyuan
XUE, Sijing
CHEN, Zhaoqiang
SHI, Yulong
CHEN, Bin
WANG, Shaohui
Priority Data
202410407014.9
03.04.2024
CN
202411285750.8
12.09.2024
CN
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
CNIPA
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| 译文 |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 3357 | |
| EPO | Filing, Examination, Granting | 20921 | |
| Japan | Filing, Examination, Granting | 2400 | |
| South Korea | Filing, Examination, Granting | 2695 | |
| USA | Filing, Examination, Granting | 6690 |
Total:
36,063
Contact Us
Abstract[English]
The present application provides a compound, a pharmaceutical composition comprising same, and a use thereof. The compound has a structure as represented by formula 0.[French]
La présente invention concerne un composé, une composition pharmaceutique le contenant et son utilisation. Le composé a une structure telle que représentée par la formule 0.[Chinese]
本申请提供了一种化合物、包含其的药物组合物及其用途，该化合物具有式0所示结构，